A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
Authors
Keywords
Parkinson’s disease, Alpha-synuclein, Acid-β-glucosidase, Mouse model, Chaperone, Motor behavior
Journal
Neurotherapeutics
Volume 11, Issue 4, Pages 840-856
Publisher
Springer Nature
Online
2014-07-19
DOI
10.1007/s13311-014-0294-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons
- (2014) Franziska Richter et al. NEUROBIOLOGY OF DISEASE
- Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease: Fig. 1.
- (2013) Anthony H. V. Schapira et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies
- (2013) S. Pablo Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein
- (2012) Melanie B. Watson et al. EXPERIMENTAL NEUROLOGY
- Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity
- (2012) Thai Leong Yap et al. MOLECULAR GENETICS AND METABOLISM
- A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice
- (2012) Marie-Francoise Chesselet et al. Neurotherapeutics
- Acid β-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α-synuclein processing
- (2011) Valerie Cullen et al. ANNALS OF NEUROLOGY
- Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
- (2011) Kenneth J. Valenzano et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- A Feedforward Loop Links Gaucher and Parkinson's Diseases?
- (2011) Mark R. Cookson CELL
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- Ex Vivoandin VivoEffects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
- (2011) Ying Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases
- (2011) Thai Leong Yap et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhanced Phosphatase Activity Attenuates -Synucleinopathy in a Mouse Model
- (2011) K.-W. Lee et al. JOURNAL OF NEUROSCIENCE
- Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein
- (2011) Hoa A. Lam et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Modelling of Parkinson's disease in mice
- (2011) Marie-Françoise Chesselet et al. LANCET NEUROLOGY
- Isofagomine In Vivo Effects in a Neuronopathic Gaucher Disease Mouse
- (2011) Ying Sun et al. PLoS One
- CNS expression of glucocerebrosidase corrects -synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
- (2011) S. P. Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Lysosomal Lair for a Pathogenic Protein Pair
- (2011) T. M. Dawson et al. Science Translational Medicine
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
- (2010) Walter J. Schulz-Schaeffer ACTA NEUROPATHOLOGICA
- The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
- (2010) Richie Khanna et al. FEBS Journal
- The risk of Parkinson’s disease in type 1 Gaucher disease
- (2010) Gilberto Bultron et al. JOURNAL OF INHERITED METABOLIC DISEASE
- A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions
- (2010) Sheila M. Fleming et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Genetic Analysis of Pathways to Parkinson Disease
- (2010) John Hardy NEURON
- Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant -Synuclein
- (2009) X.-H. Lu et al. JOURNAL OF NEUROSCIENCE
- Alpha-synuclein and familial Parkinson's disease
- (2009) Nathan Pankratz et al. MOVEMENT DISORDERS
- Alterations in corticostriatal synaptic plasticity in mice overexpressing human α-synuclein
- (2009) J.B. Watson et al. NEUROSCIENCE
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Olfactory deficits in mice overexpressing human wildtype -synuclein
- (2008) Sheila M. Fleming et al. EUROPEAN JOURNAL OF NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now